CGCHealthcare · Drug Manufacturers - Specialty & GenericThe 8 Wall Street analysts covering Canopy Growth Corp. hold a median 12-month price target of $0.92 — +21.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 42 of 100 as at 9 Oct 2026 — in the lower half.
Consensus tells you what everyone already believes. The model scores Canopy Growth Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Revisions (70): Analysts have, on balance, been raising their forecasts.
Momentum (10): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on CGC, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +21.9% from it.
Of the 20 most recent actions, 4 moved their price target up and 11 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 10 Nov 2025 | Benchmark | Upgrade | Hold | — |
| 27 Mar 2025 | Zuanic & Associates | Initiates | Neutral | — |
| 9 July 2024 | Piper Sandler | Maintains | Underweight | — |
| 15 Sept 2023 | B of A Securities | Maintains | Underperform | $0.56 → $0.66 |
| 12 June 2023 | CIBC | Maintains | Underperformer | $1.75 → $0.50 |
| 2 May 2023 | Piper Sandler | Maintains | Underweight | $2.00 → $1.00 |
| 17 Feb 2023 | Cantor Fitzgerald | Maintains | Neutral | $3.30 → $3.20 |
| 7 Nov 2022 | Cantor Fitzgerald | Maintains | Neutral | $3.05 → $3.30 |
| 2 Nov 2022 | Bernstein | Initiates | Underperform | $1.50 |
| 26 Oct 2022 | Cantor Fitzgerald | Maintains | Neutral | $2.90 → $3.05 |
| 30 Sept 2022 | Barclays | Maintains | Underweight | $3.50 → $2.00 |
| 8 Aug 2022 | Piper Sandler | Maintains | Underweight | $3.00 → $2.50 |
| 30 June 2022 | Piper Sandler | Maintains | Underweight | $4.00 → $3.00 |
| 8 June 2022 | Barclays | Maintains | Underweight | $6.00 → $3.50 |
| 31 May 2022 | Piper Sandler | Maintains | Underweight | $6.00 → $4.00 |
| 22 Mar 2022 | Barclays | Downgrade | Underweight | — |
| 1 Mar 2022 | Barclays | Maintains | Equal-Weight | $14 → $9.00 |
| 18 Feb 2022 | Cantor Fitzgerald | Maintains | Neutral | $9.60 → $11 |
| 22 Dec 2021 | B of A Securities | Downgrade | Underperform | $19 → $10 |
| 20 Dec 2021 | Piper Sandler | Downgrade | Underweight | $11 → $7.00 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
CGC appears in the Radar on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 12 Oct 2026, Canopy Growth Corp. returned −44.7% against +20.4% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 82% of US stocks
Cheaper than 68% of US stocks
Cheaper than 81% of US stocks
Cheaper than 84% of US stocks
Higher than 58% of US stocks
Higher than 30% of US stocks
Higher than 21% of US stocks
Higher than 7% of US stocks
Higher than 24% of US stocks
Higher than 33% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Canopy Growth Corp. has a market value of $300.1M and an enterprise value of $158.4M.
Revenue in the twelve months to 30 June 2026: $293.6M. The latest quarter grew 12.5% year on year.
Net income over the same four quarters: −$236.0M, a −80.4% net margin.
Diluted earnings per share, trailing twelve months: $−0.62.
Free cash flow in the twelve months to 30 June 2026: −$83.7M.
Trailing P/E: −0.8×; forward P/E: −5.5× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Canopy Growth Corp. employs 1,128 people — $260K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Canopy Growth Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Canopy Growth Corporation (CGC) closed the most recent trading day at $0.68, up 2.42% from the previous session.
Why it matters — The update reports CGC’s latest session closing price and change from the prior trading day.
Canopy Growth announced voting results from its 2026 annual general and special meeting, which convened on September 25 and reconvened on October 23. A total of 154,837,897 common shares, representing 36.60% of the shares, were reported in the excerpt.
Why it matters — The meeting’s voting results provide CGC watchers with information about shareholder participation and governance matters.
Canopy Growth shareholders approved all matters at the reconvened 2026 Annual General and Special Meeting, including authorization for a share consolidation, the election of five directors, and the appointment of MNP LLP as fiscal 2027 auditor.
Why it matters — The approvals cover corporate governance and share-consolidation authority that CGC shareholders and observers may follow.
Canopy Growth will report its second-quarter fiscal 2027 financial results before markets open on November 6, 2026. CEO Luc Mongeau and CFO Tom Stewart will host an audio webcast after the release.
Why it matters — The announcement gives CGC watchers the date and format for the company’s upcoming results and management commentary.
Canopy Growth Corporation (CGC) closed at $0.67 in the latest trading session, down 6.67% from the prior day.
Why it matters — CGC watchers may note the session’s decline as a change in the stock’s latest trading performance.
The 8 Wall Street analysts covering Canopy Growth Corp. have a median 12-month price target of $0.92, with estimates ranging from $0.92 to $0.92. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 8 analysts covering Canopy Growth Corp., 2 rate it a Buy, 6 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Canopy Growth Corp. 42 out of 100 across roughly 4,600 US stocks as at 9 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 9 Oct 2026, Canopy Growth Corp. ranks 42 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (70 of 100).
No one can know that. What the data says: the median 12-month target from 8 analysts implies +21.9% from the last close, and Ticker Nerd's factor model ranks Canopy Growth Corp. 42 out of 100 as at 9 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Canopy Growth Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CGC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $0.92 to $0.92 over the next 12 months.
Canopy Growth Corp. returned -44.7% over the 12 months to 12 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Canopy Growth Corporation is a Canadian cannabis company focused on the production, distribution, and sale of cannabis and cannabis-related products for medical and adult-use markets. Its business spans a range of product categories, including dried flower, oils, softgels, infused pre-rolls, and vaporizers, supported by brands such as Tweed, Doja, LivRelief, Ace Valley, and Deep Space.
The most recent item we track (Zacks Investment Research, 27 Oct 2026): "Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know". Canopy Growth Corporation (CGC) closed the most recent trading day at $0.68, up 2.42% from the previous session.
Canopy Growth Corporation is a Canadian cannabis company focused on the production, distribution, and sale of cannabis and cannabis-related products for medical and adult-use markets. Its business spans a range of product categories, including dried flower, oils, softgels, infused pre-rolls, and vaporizers, supported by brands such as Tweed, Doja, LivRelief, Ace Valley, and Deep Space. The company operates through its Cannabis and Storz & Bickel segments, serving customers in Canada and selected international markets, including Europe and Germany. Canopy Growth also maintains a presence in medical cannabis and related wellness products, with an emphasis on regulated supply chains, branded consumer offerings, and international compliance capabilities. Headquartered in Smiths Falls, Ontario, Canopy Growth plays a notable role in the global cannabis market as a diversified producer and distributor with both medical and consumer-focused product lines.
CEO Mr. Luc Mongeau · 1,128 employees · Canada · https://www.canopygrowth.com
